Predictors of prostate cancer detection using an extended biopsy regimen in patients with a total PSA between 2.5 and 4.0ng/ml

被引：0
|
作者：
Stephenson, AJ
Singh, H
Canto, EI
Shariat, SF
Kattan, MW
Scardino, PT
Kadmon, D
Miles, BJ
Wheeler, TM
Slawin, KM
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37901-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [31] Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy
    Eggener, SE
    Roehl, KA
    Catalona, WJ
    JOURNAL OF UROLOGY, 2005, 174 (02): : 500 - 504
  • [32] The use of primary circulating prostate cells to detect prostate cancer in men with a serum PSA >4.0ng/ml: evidence, utility and cost-benefit
    Murray, Nigel P.
    Reyes, E.
    Orellana, N.
    Badinez, L.
    Tapia, P.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S18 - S18
  • [33] Detection Rates of Nonpalpable Prostate Cancer in Korean Men With Prostate-specific Antigen Levels Between 2.5 and 4.0 ng/mL
    Kim, Hong Seok
    Jeon, Seong Soo
    Choi, Jae Duck
    Kim, Wansuk
    Han, Deok Hyun
    Jeong, Byong Chang
    Seo, Seong Il
    Lee, Kyu Sung
    Lee, Sung Won
    Lee, Hyun Moo
    Choi, Han Yong
    UROLOGY, 2010, 76 (04) : 919 - 922
  • [34] Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL
    Li, XM
    Zhang, L
    Li, J
    Li, Y
    Wang, HL
    Ji, GY
    Kuwahara, M
    Zhao, XJ
    ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (03) : 323 - 328
  • [35] Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL
    Masaaki Kuwahara
    Asian Journal of Andrology, 2005, (03) : 323 - 328
  • [36] Prostate-specific antigen (PSA) complexed to A1-antichymotrypsin is more useful for discrimination between prostate cancer and benign prostatic hyperplasia in men with a total PSA level of 2.5 to 4.0 ng/ml
    Kobayashi, T
    Nishizawa, K
    Ogura, K
    JOURNAL OF UROLOGY, 2003, 169 (04): : 277 - 277
  • [37] Prostate biopsy findings in the extended biopsy era for PSA lower than 4ng/ml
    Leite, Katia R. M.
    Srougi, Miguel
    Dall'Oglio, Marcos F.
    Antunes, Alberto A.
    Cury, Jose
    Sanudo, Adriana
    Camara-Lopes, Luiz Heraldo A.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 583 - 583
  • [38] EARLY DETECTION OF PROSTATE CANCER IN PATIENT WITH PROSTATIC SPECIFIC ANTIGEN LEVELS OF 2.5 TO 4.0 NG/ML
    Shah, S.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A26 - A26
  • [39] Epidemiological evidence suggesting a PSA cutpoint of 2.5 ng/ml for initiating a prostate biopsy: A review of 36,316 patients with biopsy and PSA data
    Lowe, FC
    Cavallo, CB
    Kahane, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 341 - 341
  • [40] COST-EFFECTIVENESS OF PERCENT FREE PSA FOR PROSTATE CANCER DETECTION IN CHINESE MEN WITH A TOTAL PSA OF 4.0-10.0 NG/ML LAI AYH
    Lai, A. Y. H.
    VALUE IN HEALTH, 2014, 17 (07) : A812 - A812
12345